Worhunsky David J, Zak Yulia, Dua Monica M, Poultsides George A, Norton Jeffrey A, Visser Brendan C
Division of Surgical Oncology, Department of Surgery, Stanford University Medical Center, 300 Pasteur Drive, Suite H3680C, Stanford, CA, 94305, USA.
J Gastrointest Surg. 2014 Aug;18(8):1445-51. doi: 10.1007/s11605-014-2561-x. Epub 2014 Jun 18.
Splenic preservation is currently recommended during minimally invasive surgery for benign tumors of the distal pancreas. The aim of this study was to evaluate the outcomes of patients undergoing laparoscopic spleen-preserving distal pancreatectomy, with particular attention paid to the technique used for spleen preservation (splenic vessel ligation vs preservation). A review of consecutive patients who underwent laparoscopic distal pancreatectomy with the intention of splenic preservation was conducted. Patient demographics, operative data, and outcomes were collected and analyzed. Fifty-five consecutive patients underwent laparoscopic distal pancreatectomy with the intention of splenic preservation; 5 required splenectomy (9 %). Of the remaining 50 patients, 31 (62 %) had splenic vessel ligation, and 19 (38 %) had vessel preservation. Patient demographics and tumor size were similar. The vessel ligation group had significantly more pancreas removed (95 vs 52 mm, P < 0.001) and longer operative times (256 vs 201 min, P = 0.008). Postoperative outcomes, complication rates, and splenic viability were similar between groups. Laparoscopic spleen-preserving distal pancreatectomy is a safe operation with a high rate of success (91 %). Vessel ligation was the chosen technical strategy for lesions that required resection of a greater length of pancreas. We found no advantage to either technique with respect to outcomes and splenic preservation. Operative approach should reflect technical considerations including location in the pancreas.
目前,对于胰腺远端良性肿瘤的微创手术,建议保留脾脏。本研究的目的是评估接受腹腔镜保留脾脏远端胰腺切除术患者的手术结果,尤其关注用于保留脾脏的技术(脾血管结扎与保留)。对连续接受腹腔镜远端胰腺切除术且旨在保留脾脏的患者进行了回顾性研究。收集并分析了患者的人口统计学数据、手术数据和手术结果。55例连续患者接受了旨在保留脾脏的腹腔镜远端胰腺切除术;5例需要行脾切除术(9%)。在其余50例患者中,31例(62%)进行了脾血管结扎,19例(38%)进行了血管保留。患者的人口统计学数据和肿瘤大小相似。血管结扎组切除的胰腺组织明显更多(95 vs 52 mm,P<0.001),手术时间更长(256 vs 201 min, P = 0.008)。两组之间的术后结果、并发症发生率和脾脏活力相似。腹腔镜保留脾脏远端胰腺切除术是一种成功率高(91%)的安全手术。对于需要切除更长胰腺长度的病变,血管结扎是首选的技术策略。我们发现,在手术结果和脾脏保留方面,两种技术均无优势。手术方式应反映技术考量因素,包括胰腺病变位置在内。